Extended-Field Chemoradiation Therapy for Definitive Treatment of Anal Canal Squamous Cell Carcinoma Involving the Para-Aortic Lymph Nodes
Emma B. Holliday(The University of Texas MD Anderson Cancer Center), Christopher L. Hallemeier(Mayo Clinic in Arizona), Michael G. Haddock(Mayo Clinic in Arizona), Scott C. Lester(Mayo Clinic in Arizona), Prajnan Das(The University of Texas MD Anderson Cancer Center), Cathy Eng(Vanderbilt University), Sunil Krishnan(The University of Texas Health Science Center at Houston), William S. Harmsen(Mayo Clinic)
Cited by 27
Related Papers
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Treatment of Metastatic Colorectal Cancer: ASCO Guideline
|Journal of Clinical Oncology|2022|580
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer
|Annals of Surgery|2019|445
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper
|Nature Reviews Clinical Oncology|2020|365